vs

Side-by-side financial comparison of APPFOLIO INC (APPF) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $262.2M, roughly 1.9× APPFOLIO INC). APPFOLIO INC runs the higher net margin — 16.2% vs -10.1%, a 26.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 20.4%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 15.3%).

AppFolio, Inc. is an American company founded in 2006 that offers software-as-a-service (SaaS) applications and services to the real estate industry.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

APPF vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.9× larger
CLOV
$487.7M
$262.2M
APPF
Growing faster (revenue YoY)
CLOV
CLOV
+24.3% gap
CLOV
44.7%
20.4%
APPF
Higher net margin
APPF
APPF
26.3% more per $
APPF
16.2%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
15.3%
APPF

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
APPF
APPF
CLOV
CLOV
Revenue
$262.2M
$487.7M
Net Profit
$42.4M
$-49.3M
Gross Margin
Operating Margin
19.4%
-10.1%
Net Margin
16.2%
-10.1%
Revenue YoY
20.4%
44.7%
Net Profit YoY
35.2%
-123.2%
EPS (diluted)
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APPF
APPF
CLOV
CLOV
Q1 26
$262.2M
Q4 25
$248.2M
$487.7M
Q3 25
$249.4M
$496.6M
Q2 25
$235.6M
$477.6M
Q1 25
$217.7M
$462.3M
Q4 24
$203.7M
$337.0M
Q3 24
$205.7M
$331.0M
Q2 24
$197.4M
$356.3M
Net Profit
APPF
APPF
CLOV
CLOV
Q1 26
$42.4M
Q4 25
$39.9M
$-49.3M
Q3 25
$33.6M
$-24.4M
Q2 25
$36.0M
$-10.6M
Q1 25
$31.4M
$-1.3M
Q4 24
$102.7M
$-22.1M
Q3 24
$33.0M
$-9.2M
Q2 24
$29.7M
$7.4M
Gross Margin
APPF
APPF
CLOV
CLOV
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
APPF
APPF
CLOV
CLOV
Q1 26
19.4%
Q4 25
17.6%
-10.1%
Q3 25
14.1%
-4.9%
Q2 25
17.2%
-2.2%
Q1 25
15.5%
-0.3%
Q4 24
11.3%
-6.4%
Q3 24
20.7%
-2.7%
Q2 24
18.3%
2.0%
Net Margin
APPF
APPF
CLOV
CLOV
Q1 26
16.2%
Q4 25
16.1%
-10.1%
Q3 25
13.5%
-4.9%
Q2 25
15.3%
-2.2%
Q1 25
14.4%
-0.3%
Q4 24
50.4%
-6.6%
Q3 24
16.0%
-2.8%
Q2 24
15.0%
2.1%
EPS (diluted)
APPF
APPF
CLOV
CLOV
Q1 26
$1.18
Q4 25
$1.10
Q3 25
$0.93
Q2 25
$0.99
Q1 25
$0.86
Q4 24
$2.79
Q3 24
$0.90
Q2 24
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APPF
APPF
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$147.4M
$78.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$470.2M
$308.7M
Total Assets
$580.6M
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APPF
APPF
CLOV
CLOV
Q1 26
$147.4M
Q4 25
$107.0M
$78.3M
Q3 25
$76.1M
Q2 25
$73.5M
Q1 25
$56.9M
Q4 24
$42.5M
$194.5M
Q3 24
$62.4M
$288.0M
Q2 24
$59.6M
$254.8M
Stockholders' Equity
APPF
APPF
CLOV
CLOV
Q1 26
$470.2M
Q4 25
$542.6M
$308.7M
Q3 25
$498.9M
$340.9M
Q2 25
$455.6M
$344.2M
Q1 25
$462.1M
$336.1M
Q4 24
$519.3M
$341.1M
Q3 24
$412.8M
$342.2M
Q2 24
$371.4M
$324.9M
Total Assets
APPF
APPF
CLOV
CLOV
Q1 26
$580.6M
Q4 25
$689.0M
$541.0M
Q3 25
$640.5M
$559.7M
Q2 25
$567.4M
$575.0M
Q1 25
$564.7M
$583.7M
Q4 24
$626.7M
$580.7M
Q3 24
$523.3M
$653.0M
Q2 24
$479.3M
$674.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APPF
APPF
CLOV
CLOV
Operating Cash FlowLast quarter
$34.3M
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
0.81×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APPF
APPF
CLOV
CLOV
Q1 26
$34.3M
Q4 25
$65.0M
$-66.9M
Q3 25
$86.0M
$12.1M
Q2 25
$52.6M
$5.4M
Q1 25
$38.5M
$-16.3M
Q4 24
$36.6M
$34.8M
Q3 24
$57.8M
$50.0M
Q2 24
$50.9M
$44.8M
Free Cash Flow
APPF
APPF
CLOV
CLOV
Q1 26
Q4 25
$63.7M
$-69.0M
Q3 25
$84.7M
$11.4M
Q2 25
$52.4M
$4.8M
Q1 25
$38.2M
$-16.5M
Q4 24
$36.4M
$33.3M
Q3 24
$57.4M
$49.6M
Q2 24
$50.8M
$44.4M
FCF Margin
APPF
APPF
CLOV
CLOV
Q1 26
Q4 25
25.7%
-14.1%
Q3 25
34.0%
2.3%
Q2 25
22.2%
1.0%
Q1 25
17.6%
-3.6%
Q4 24
17.9%
9.9%
Q3 24
27.9%
15.0%
Q2 24
25.8%
12.5%
Capex Intensity
APPF
APPF
CLOV
CLOV
Q1 26
Q4 25
0.5%
0.4%
Q3 25
0.5%
0.1%
Q2 25
0.1%
0.1%
Q1 25
0.1%
0.0%
Q4 24
0.1%
0.5%
Q3 24
0.2%
0.1%
Q2 24
0.0%
0.1%
Cash Conversion
APPF
APPF
CLOV
CLOV
Q1 26
0.81×
Q4 25
1.63×
Q3 25
2.56×
Q2 25
1.46×
Q1 25
1.23×
Q4 24
0.36×
Q3 24
1.75×
Q2 24
1.71×
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APPF
APPF

Value Added Services$201.4M77%
Subscription Services$58.2M22%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons